Once again it is Sunday and not much new to report…..Sex is always a good subject…..It is Sexy Sunday!
Intrinsa was recently licensed in the UK for the treatment of women, who have gone through the menopause
as a result of womb and ovary removal, and who are subsequently experiencing a drop in sex drive.
The condition is referred to as hypoactive sexual desire disorder or HSDD for short.
There is some evidence to suggest that a fall in sex drive after the menopause might be linked to low levels of circulating testosterone.
Intrinsa is prescribed for women with HSDD, who are receiving oestrogen replacement therapy. It delivers a daily dose of testosterone from a patch replaced twice weekly and worn continuously on the lower abdomen.
The key trials on testosterone patches have involved highly selective groups of women – excluding, for example, those with various mental or physical conditions that could affect sex drive, says DTB. And in some trials a diagnosis of HSDD was made on the basis of short, unvalidated questionnaires.
There was also a large placebo response in the studies, with significant numbers of women not treated with the patch reporting improved sex drive, which indicates that low hormone levels might not have been the problem, says DTB.
Furthermore, the improvements were small. And the fact that some of the women were already having sex twice or three times a month before they entered the trials, raises questions about whether they really had a poor sex drive in the first place.